Crossmark

The 18 F phantom clinical trials qualification for 18F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autologo de Médula Ósea)

Crossref DOI link: https://doi.org/10.1016/j.remnie.2020.06.011

Published Print: 2021-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bergesio, Fabrizio

Maggi, Adriano De

Coronado, Mónica

Pardal, Emilia

Plaza, Rafael

Hernández, Ana Cristina

Sarandeses, Maria del Pilar

Cortes, Montserrat

Setoain, Xavier

Simó, Marc

Rotger, Amanda

Grande, Carlos

Caballero, Maria Dolores

Chauvie, Stephane
License Information

Text and Data Mining valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: The 18 F phantom clinical trials qualification for 18F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autologo de Médula Ósea)

Journal Title: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.remnie.2020.06.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.remn.2020.06.003

Content Type: article

Copyright: © 2020 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below